Haisco Pharmaceutical Grou (002653.SZ) traded flat 0 % during a 24 hours period ending at 05:40 AM Central Europe on Wednesday 28th. One Haisco Pharmaceutical Grou stock can currently be bought for about CNY 57.5 on popular exchanges. Current supply of Haisco Pharmaceutical Grou stocks is 1.1 bn. Haisco Pharmaceutical Grou has a current market capitalization of CNY 65.1 bn and approximately CNY 311.6 mn worth of Haisco Pharmaceutical Grou was traded on exchanges in the last 24 hours. Since last month end, Haisco Pharmaceutical Grou has traded -3.31 % down. Simple moving average of last 200 days is at CNY 62.65. The highest price of past 52 weeks was recorded at CNY 80.83 on 07/06/2026. 52 weeks low was at CNY 42.38 on 03/04/2026.

Here is how related stocks have performed in the past 24 hours:

  • Ningbo Tuopu (601689.SS) traded flat 0 % and now trades at CNY 46.63. Ningbo Tuopu has a market capitalisation of CNY 77.9 bn. Current price/earnings ratio for Ningbo Tuopu is 30.72.

  • Huaneng Power -H (0902.HK) traded up 0.8 % and now trades at HKD 5.78. Huaneng Power -H has a market capitalisation of HKD 89.9 bn. Huaneng Power -H has a current price to earnings ratio of 6.65.

  • Sinotruk Hong Kong (3808.HK) traded up 0.62 % and now trades at HKD 32.7. Current market capitalisation for Sinotruk Hong Kong is HKD 89.7 bn. Sinotruk Hong Kong has a current price to earnings ratio of 9.71.

  • Power Construction Of (601669.SS) traded flat 0 % and now trades at CNY 4.44. Current market capitalisation for Power Construction Of is CNY 77.5 bn. Power Construction Of has a current price to earnings ratio of 10.2.

  • Zhangzhou Pientzehuang Pha (600436.SS) traded flat 0 % and now trades at CNY 127.92. Current market capitalisation for Zhangzhou Pientzehuang Pha is CNY 77.4 bn. Current price/earnings ratio for Zhangzhou Pientzehuang Pha is 41.69.

About Haisco Pharmaceutical Grou

Haisco Pharmaceutical Group Co., Ltd. is a health care sector company based in Shannan, China. The company specializes in developing, manufacturing, and selling drug formulations and active pharmaceutical ingredients. They produce hepatobiliary disease medications, anti-infective drugs, nutrition drugs, and related products. Haisco markets its products throughout China. The company’s website is www.haisco.com and it is listed on the Shenzhen Stock Exchange. The IPO date was December 29, 2011.